课题基金 / 基金详情

PROJECT 10

PROJECT 10
项目10
批准号:
7932933
负责人:
JONGYOON HAN
金额:
$8.66万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
关键词:
AddressAlgorithmsAnalytical ChemistryApoptosisApoptoticAreaBiochemical PathwayBiologyBiophysicsBostonCalibrationCaspaseCell Culture SystemCellsCellular biologyCessation of lifeChemistryCollaborationsCommunitiesCommunity DevelopmentsComplexComputer softwareComputing MethodologiesDataDevelopmentDevicesDisadvantagedDiseaseDoctor of PhilosophyDocumentationEducation and OutreachEngineeringEpidermal Growth Factor ReceptorEquilibriumEuropeFacultyGoalsGrowth FactorGrowth Factor ReceptorsHepatocyteHispanicsHomeostasisHumanImmuneIndividualInflammatoryInformation TechnologyInstitutionInsulin-Like Growth Factor IInternationalKineticsLabelLeast-Squares AnalysisLifeLigandsLinkLogicMalignant NeoplasmsMammalian CellMass Spectrum AnalysisMeasurementMediatingMethodsMicrofluidic MicrochipsMinority-Serving InstitutionModelingMolecularMonitorPathway interactionsPeptidesPharmacologic SubstancePhysiologicalPopulationPositioning AttributeProcessProtein ArrayProteinsReactionResearchResearch PersonnelResearch Project GrantsResolutionRunningScientistSet proteinSignal TransductionSignal Transduction PathwaySiteSoftware ToolsStagingStressStudentsSystems BiologyT-Cell ReceptorT-LymphocyteTNF geneTNFSF10 geneTechnologyTestingTissuesTrainingValidationVariantWeightWomanbasecancer cellcareercell growthcell transformationcell typecellular imagingcomputerized data processingcytokinedata modelingdata sharingdesigngraduate studenthigh schoolhuman diseaseimaging modalityimprovedinterestmathematical modelmembermicrosystemsmodel developmentneutrophilnovelnovel strategiesphysical scienceprogramsprotein functionreceptorresponsesuccesssymposium

项目摘要

项目成果

JONGYOON HAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Center for Cell Decision Processes at MIT (CDP Center; www.cdpcenter.org) applies a modiry-measuremine- model paradigm to study receptor-mediated death and survival signaling in human cells. Pro-apoptotic and inflammatory pathways downstream of TNF, TRAIL and Fas death receptors are of particular interest, as are the pro-survival and mitogenic pathways activated by the six interacting ErbBl-4, IGF-1 and cMet growth factor receptors and by the T-cell receptor. The primary goal of the Center is to build mathematical models of signal transduction using a variety of methods ranging from statistical to physicochemical. All models incorporate empirical data and are subjected to rigorous experimental validation. To collect and systematize the data necessary to train and test models, the Center develops new mass spectrometry, microsystems and imaging methods as well as software to link data and models. Education, outreach and community development are core activities of the Center, and it will continue to support activities ranging from summer courses for high school students to sabbaticals for established scientists and engineers from minority-serving institutions, international conferences in systems biology and interdisciplinary communities it has established including CSBi at MIT and the Council for Systems Biology in Boston. CDP will build on its success in research through a five-part program that stresses (1) construction, calibration and validation of models of mammalian signaling processes in accessible cell-culture systems, (2) development of new experimental methods to gather quantitative and dynamic data from small cell populations and single-cells via array-based measurement, development of microfluidic devices and new approaches to live-cell imaging, (3) an emphasis on the systems biology of specialized cells, as it applies to primary T-cells, human hepatocytes and human neutrophils and to differences between healthy and diseased states in inflammatory disease and cancer, (4) continued development of electronically enabled research cores and information technologies, particularly those that enhance data sharing and collaboration, and (5) continued commitment to outreach and education through balanced programs with broad impact and those with the potential to substantially enhance individual careers
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Continuous Production of Viral Vectors using membraneless Perfusion Culture of Host Cells
Flexible Platform for End-to-end Manufacturing of Gene Therapies to Advance Development of Treatments for Ultra-rare Diseases
Flexible Platform for End-to-end Manufacturing of Gene Therapies to Advance Development of Treatments for Ultra-rare Diseases
Flexible Platform for End-to-end Manufacturing of Gene Therapies to Advance Development of Treatments for Ultra-rare Diseases
海外基金